Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Ladoire

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosisOlivier Facy, François Radais, Sylvain Ladoire, et al.
Surgery|July 17, 2014
High pressure does not counterbalance the advantages of open techniques over closed techniques during heated intraperitoneal chemotherapy with oxaliplatinOlivier Facy, Christophe Combier, Matthieu Poussier, et al.
EJNMMI Research|July 4, 2024
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancerNeree Payan, Benoit Presles, Charles Coutant, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 24, 2025
Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypesLoup Guichard, Prescillia Nunes, Clémentine Jankowski, et al.
British Journal of Cancer|April 29, 2023
Anticipating changes in the HER2 status of breast tumours with disease progression-towards better treatment decisions in the new era of HER2-low breast cancersAnthony Bergeron, Aurélie Bertaut, Françoise Beltjens, et al.
BMC Infectious Diseases|March 28, 2008
Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteriaPierre Emmanuel Charles, Sylvain Ladoire, Serge Aho, et al.
Antioxidants & Redox Signaling|February 12, 2013
Cell-death-associated molecular patterns as determinants of cancer immunogenicitySylvain Ladoire, Dalil Hannani, Marie Vetizou, et al.
Cancer Research|April 15, 2010
5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunityJulie Vincent, Grégoire Mignot, Fanny Chalmin, et al.
Oncoimmunology|March 5, 2016
Human ectonucleotidase-expressing CD25<sup>high</sup> Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functionsMarion Thibaudin, Marie Chaix, Romain Boidot, et al.
Annales De Pathologie|February 5, 2017
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives]Sylvain Ladoire, Valentin Derangère, Laurent Arnould, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Journal of Experimental & Clinical Cancer Research : CR|January 11, 2011
Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosisOlivier Facy, François Radais, Sylvain Ladoire, et al.
Surgery|July 17, 2014
High pressure does not counterbalance the advantages of open techniques over closed techniques during heated intraperitoneal chemotherapy with oxaliplatinOlivier Facy, Christophe Combier, Matthieu Poussier, et al.
EJNMMI Research|July 4, 2024
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancerNeree Payan, Benoit Presles, Charles Coutant, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 24, 2025
Value of early metabolic response for predicting axillary pathological complete response during neoadjuvant systemic therapy in triple negative and HER2-amplified breast cancers: impact of tumor subtypesLoup Guichard, Prescillia Nunes, Clémentine Jankowski, et al.
British Journal of Cancer|April 29, 2023
Anticipating changes in the HER2 status of breast tumours with disease progression-towards better treatment decisions in the new era of HER2-low breast cancersAnthony Bergeron, Aurélie Bertaut, Françoise Beltjens, et al.
BMC Infectious Diseases|March 28, 2008
Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteriaPierre Emmanuel Charles, Sylvain Ladoire, Serge Aho, et al.
Antioxidants & Redox Signaling|February 12, 2013
Cell-death-associated molecular patterns as determinants of cancer immunogenicitySylvain Ladoire, Dalil Hannani, Marie Vetizou, et al.
Cancer Research|April 15, 2010
5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunityJulie Vincent, Grégoire Mignot, Fanny Chalmin, et al.
Oncoimmunology|March 5, 2016
Human ectonucleotidase-expressing CD25<sup>high</sup> Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functionsMarion Thibaudin, Marie Chaix, Romain Boidot, et al.
Annales De Pathologie|February 5, 2017
[The anti-tumor immune response in breast cancer: Update and therapeutic perspectives]Sylvain Ladoire, Valentin Derangère, Laurent Arnould, et al.
Pageof 17